The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 52 results:
Author Title Type [ Year(Asc)]
Filters: Author is Kotsis, Vasilios  [Clear All Filters]
2019
Karava, V., Printza N., Dotis J., Demertzi D., Antza C., Kotsis V., et al. (2019).  Body composition and arterial stiffness in pediatric patients with chronic kidney disease.. Pediatr Nephrol. 34(7), 1253-1260.
Stabouli, S., Printza N., Zervas C., Dotis J., Chrysaidou K., Maliahova O., et al. (2019).  Comparison of the SphygmoCor XCEL device with applanation tonometry for pulse wave velocity and central blood pressure assessment in youth.. J Hypertens. 37(1), 30-36.
Doundoulakis, I., Antza C., Kotsis V., & Giannakoulas G. (2019).  A gut feeling about children's exposure to hypertensive disorders of pregnancy in utero.. Eur J Prev Cardiol. 2047487319857213.
Natsis, M., Antza C., Doundoulakis I., Stabouli S., & Kotsis V. (2019).  Hypertension in obesity: novel insights.. Curr Hypertens Rev.
Patoulias, D., Doumas M., Kotsis V., Stavropoulos K., Imprialos K., Zografou I., et al. (2019).  Liraglutide as adjunct to insulin treatment in patients with type 1 diabetes: A systematic review and meta-analysis.. Curr Diabetes Rev.
Antza, C., Doundoulakis I., Akrivos E., Economou F., Vazakidis P., Haidich A-B., et al. (2019).  Non-vitamin K oral anticoagulants in nonvalvular atrial fibrillation: a network meta-analysis.. Scand Cardiovasc J. 53(2), 48-54.
Nika, T., Stabouli S., Kollios K., Papadopoulou-Legbelou K., Printza N., Antza C., et al. (2019).  Obesity and season as determinants of high blood pressure in a school-based screening study.. J Hum Hypertens. 33(4), 277-285.
Stabouli, S., Nika T., Kollios K., Antza C., Doundoulakis I., & Kotsis V. (2019).  Performance of simplified tables for high blood pressure screening in a European pediatric population.. J Hypertens. 37(5), 917-922.
Giannopoulou, E. Z., Doundoulakis I., Antza C., Christoforidis A., Haidich A-B., Kotsis V., et al. (2019).  Subclinical arterial damage in children and adolescents with type 1 diabetes: A systematic review and meta-analysis.. Pediatr Diabetes. 20(6), 668-677.
Dimou, C., Antza C., Akrivos E., Doundoulakis I., Stabouli S., Haidich A. Bettina, et al. (2019).  A systematic review and network meta-analysis of the comparative efficacy of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension.. J Hum Hypertens. 33(3), 188-201.
2018
Rizos, C. V., Elisaf M. S., Skoumas I., Tziomalos K., Kotsis V., Rallidis L., et al. (2018).  Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).. Atherosclerosis. 277, 308-313.
Antza, C., Doundoulakis I., Stabouli S., & Kotsis V. (2018).  Comparison Among Recommendations for the Management of Arterial Hypertension Issued by Last US, Canadian, British and European Guidelines.. High Blood Press Cardiovasc Prev. 25(1), 9-16.
Antza, C., Doundoulakis I., Akrivos E., Stabouli S., Trakatelli C., Doumas M., et al. (2018).  Early Vascular Aging Risk Assessment From Ambulatory Blood Pressure Monitoring: The Early Vascular Aging Ambulatory Score.. Am J Hypertens. 31(11), 1197-1204.
Mitsiou, E., Boutari C., Kotsis V., Georgianou E., Doumas M., Karagiannis A., et al. (2018).  Effect of Low (5 mg) vs. High (20-40 mg) Rosuvastatin Dose on 24h Arterial Stiffness, Central Haemodynamics, and Non-Alcoholic Fatty Liver Disease in Patients with Optimally Controlled Arterial Hypertension.. Curr Vasc Pharmacol. 16(4), 393-400.
Kotsis, V., Jordan J., Micic D., Finer N., Leitner D. R., Toplak H., et al. (2018).  Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part A: mechanisms of obesity induced hypertension. J Hypertens. 36(7), 1427-1440.
Kotsis, V., Tsioufis K., Antza C., Seravalle G., Coca A., Sierra C., et al. (2018).  Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part B: obesity-induced cardiovascular disease, ea. J Hypertens. 36(7), 1441-1455.
Doundoulakis, I., Antza C., Apostolidou-Kiouti F., Akrivos E., Karvounis H., Kotsis V., et al. (2018).  Overview of Systematic Reviews of Non-Vitamin K Oral Anticoagulants in Atrial Fibrillation.. Circ Cardiovasc Qual Outcomes. 11(12), e004769.
Kotsis, V. (2018).  Treatment of Hypertension Induced Target Organ Damage.. Curr Pharm Des. 24(37), 4377.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.